found that in primary malignant glioma cultures and high-grade glioma sources, TRIM11 expression was upregulated, and overexpression of TRIM11 may lead to a more aggressive glioma phenotype, increased malignant tumour growth and low survival [21]. The gene discussed is TRIM11; the disease is central nervous system cancer.